Rewalk Robotics

Beleggen in aandelen beurs New York, Dow Jones index, Nasdaq-100 en S&P500
Plaats reactie
Munnybunny
Forum actieveling
Forum actieveling
Berichten: 856
Lid geworden op: 17 Sep 2014 14:20
Likes: 346
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 15 Dec 2017 19:31

Patient to be Discharged from Burke Rehabilitation Hospital with ReWalk Robotic Exoskeleton Device -Burke to successfully discharge first patient with ReWalk device in region-

White Plains, NY, (December 14, 2017) – Burke Rehabilitation Hospital has announced it will discharge a patient with a ReWalk robotic exoskeleton device on Wednesday, December 20, 2017 at Noon. This will be the first discharge home of a patient in the region with the robotic device—a wearable exoskeleton that provides powered hip and knee motion to enable the individual to stand upright, walk and turn. This pivotal event in rehabilitative medicine will take place at Burke’s main lobby (Wood Building) at 785 Mamaroneck Avenue in White Plains, NY.

Rusty is a 39-year-old Slovakian-born patient who was employed in New York as a construction worker. In 2008, his entire life changed in a split second when he fell from the roof of a house approximately 32 feet high, and the fall caused a spinal cord injury that left him paralyzed from the waist down. Post-injury, Rusty was involved in various therapies, interventions and treatments at Burke Rehabilitation Hospital.

https://www.burke.org/media/press/2017/ ... tation/151


Munnybunny
Forum actieveling
Forum actieveling
Berichten: 856
Lid geworden op: 17 Sep 2014 14:20
Likes: 346
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 01 Feb 2018 12:38

Eindelijk nog een keer dik nieuws. Terugbetaling door nieuwe Duitse verzekeraar. Zal nu wel uit de range 1.05-1.10 breken.

German National Health Insurance Agency Announces Addition of ReWalk 6.0 System to National Medical Device Directory
By Jasmine Petters , in PR PR Health on February 1, 2018 .

MARLBOROUGH, Mass. and BERLIN, Feb. 1, 2018 — GKV-Spitzenverband, the head office of German statutory health insurance (SHI), confirmed their decision to list the ReWalk (Nasdaq: RWLK) Personal 6.0 Exoskeleton System in the German Medical Device Directory (MDD, Hilfsmittelverzeichnis), according to §139 SGB V. The MDD is a comprehensive list of all medical devices which are principally and regularly reimbursed by German SHI providers. This decision means that ReWalk will be listed among all medical devices for compensation, which SHI providers can procure for any approved beneficiary on a case-by-case basis.


The ReWalk Personal will be classified as “an innovative device for the immediate compensation of a handicap” in the MDD, and will be listed under a new subcategory for product group 23. The official publication of the MDD, which is issued annually, is expected within the next three months.

Addition to the MDD is a significant policy milestone, allowing for any eligible German SHI beneficiary in the country to seek procurement of a ReWalk system to stand and walk again. If their assessment is approved by physical exam, the SHI will then reimburse for purchase of a system. Ninety percent of the German population are beneficiaries under SHI coverage, which creates the potential for thousands of individuals with spinal cord injury (SCI) in Germany to have access to exoskeleton devices for the first time. 

“We are pleased to see the German healthcare system embracing biotechnology innovations that will be life changing for beneficiaries nationwide,” said ReWalk CEO Larry Jasinski. “This is a landmark decision—one of progressive policy by SHI in Germany, and one that will be critically important to SCI individuals across the country. We are excited to announce that patients and O&P shops will soon be able to access ReWalk systems as a part of the standard reimbursement process.”

The GKV decision follows a similar policy issuance by German accident insurer BG in 2017, which provided for rental and procurement of ReWalk 6.0 Personal Systems for qualifying beneficiaries.  Receiving its CE Mark in 2012, ReWalk has been working with insurers across the EU on policy development for SCI beneficiaries.  There are more than 400 ReWalk systems in use worldwide today.

To learn more about the ReWalk 6.0 System, please visit: http://www.rewalk.com
ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.

Munnybunny
Forum actieveling
Forum actieveling
Berichten: 856
Lid geworden op: 17 Sep 2014 14:20
Likes: 346
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 01 Feb 2018 12:46

Next-Generation Exoskeletons Help Patients Move

A robot’s gentle nudge could add just the right amount of force to improve walking for patients with mobility-impairing ailments such as Parkinson’s disease, multiple sclerosis, and stroke.

By Karen Weintraub | February 1, 2018


A VIABLE MARKET?
Larry Jasinski, CEO of ReWalk Robotics, says he’s convinced there’s a broad market for new exosuits. ReWalk made its name developing rigid exoskeletons for people with spinal cord injury, and now has FDA approval for a device that allows paralyzed people to stand and walk. But he says at least one-third of the calls he gets are from patients with motor neuron diseases asking him when he’s going to make something that can help them. “It tells me that we have an audience here that’s actually bigger than the spinal cord community,” he says.

He says he’s hoping that within a few years he will be able to offer even less-expensive suits tailored for other patients: people suffering from multiple sclerosis or Parkinson’s disease who need even lighter movement nudges. Jasinski says he expects to round out the offerings with exosuits aimed at people with cerebral palsy and the elderly, once the suit can be redesigned and tested for them. “If we can handle all those, we’ve got a very large industry,” he says.

These newer devices would cost a lot less—on the order of just $19,500—than the whole-body exoskeletons for paraplegics, which run about $80,000, says Jasinski, who notes that rehabilitation hospitals could be financially motivated to buy the suits because fewer staff members will be needed to work with each patient. At-home costs may be harder to justify to an insurance company, at least at first, he says. But a patient might be able to rent the suit as needed, to bring the price down to a manageable sum. “I can make that work from a business model.”

....

A handful of other research teams are also developing soft exosuits for patients with movement disorders.

A Belgian group at Ghent University is also aiming to help the elderly get around, and just last year the researchers showed that the exosuit they built to assist with plantarflexion—the “push-off” stage of walking—can reduce the effort it takes for a person over the age of 65 to walk

https://www.the-scientist.com/?articles ... ents-Move/

Munnybunny
Forum actieveling
Forum actieveling
Berichten: 856
Lid geworden op: 17 Sep 2014 14:20
Likes: 346
Contact:

Re: Rewalk Robotics

Berichtdoor Munnybunny » 01 Feb 2018 15:21

ReWalk@ReWalk_Robotics

#Amazing news for people with #spinal cord injury in #Germany! 90% of the #German population has SHI coverage, and this creates the potential for thousands of individuals with SCI to now have access to their own #ReWalk. #rwlk #exoskeleton #healthcare
German National Health Insurance Agency Announces Addition of ReWalk 6.0 System to National Medical...


https://mobile.twitter.com/ReWalk_Robotics